By Tony Fong

NEW YORK (GenomeWeb News) – With little fanfare, Johnson & Johnson is building out its capabilities in the molecular diagnostics space with a focus on circulating tumor cells and companion diagnostics development.

In recent interviews with GenomeWeb Daily News, officials from several J&J businesses outlined a strategy focused on continuing to build out the firm's CellSearch technology as well as the development of a next-generation CTC technology in collaboration with Massachusetts General Hospital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.